News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
288,382 Results
Type
Article (17707)
Company Profile (58)
Press Release (270617)
Multimedia
Podcasts (12)
Webinars (7)
Section
Business (81297)
Career Advice (904)
Deals (14945)
Drug Delivery (56)
Drug Development (37081)
Employer Resources (111)
FDA (8481)
Job Trends (7472)
News (144241)
Policy (14417)
Tag
Academia (1413)
Academic (1)
Accelerated approval (5)
Adcomms (26)
Allergies (41)
Alliances (23206)
ALS (47)
Alzheimer's disease (808)
Antibody-drug conjugate (ADC) (71)
Approvals (8497)
Artificial intelligence (137)
Autoimmune disease (13)
Automation (11)
Bankruptcy (127)
Best Places to Work (6373)
BIOSECURE Act (4)
Biosimilars (46)
Biotechnology (46)
Bladder cancer (58)
Brain cancer (18)
Breast cancer (178)
Cancer (1381)
Cardiovascular disease (119)
Career advice (802)
Career pathing (17)
CAR-T (86)
Cell therapy (214)
Cervical cancer (13)
Clinical research (30833)
Collaboration (442)
Compensation (53)
Complete response letters (11)
COVID-19 (1214)
CRISPR (22)
C-suite (80)
Cystic fibrosis (60)
Data (1356)
Denatured (6)
Depression (19)
Diabetes (146)
Diagnostics (4356)
Digital health (7)
Diversity (2)
Diversity, equity & inclusion (19)
Drug discovery (64)
Drug pricing (79)
Drug shortages (9)
Duchenne muscular dystrophy (58)
Earnings (31822)
Editorial (16)
Employer branding (17)
Employer resources (93)
Events (34394)
Executive appointments (308)
FDA (9232)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (313)
Gene editing (50)
Generative AI (17)
Gene therapy (170)
GLP-1 (343)
Government (2218)
Grass and pollen (3)
Guidances (46)
Healthcare (8991)
Huntington's disease (12)
IgA nephropathy (14)
Immunology and inflammation (48)
Indications (20)
Infectious disease (1279)
Inflammatory bowel disease (64)
Inflation Reduction Act (4)
Influenza (19)
Intellectual property (50)
Interviews (125)
IPO (6082)
IRA (23)
Job creations (1391)
Job search strategy (701)
Kidney cancer (6)
Labor market (16)
Layoffs (160)
Leadership (11)
Legal (2603)
Liver cancer (43)
Lung cancer (219)
Lymphoma (104)
Machine learning (3)
Management (43)
Manufacturing (142)
MASH (39)
Medical device (6188)
Medtech (6190)
Mergers & acquisitions (9147)
Metabolic disorders (337)
Multiple sclerosis (40)
NASH (15)
Neurodegenerative disease (49)
Neuropsychiatric disorders (15)
Neuroscience (1076)
NextGen: Class of 2025 (2895)
Non-profit (2031)
Now hiring (13)
Obesity (152)
Opinion (107)
Ovarian cancer (46)
Pain (47)
Pancreatic cancer (41)
Parkinson's disease (73)
Partnered (14)
Patents (94)
Patient recruitment (49)
Peanut (25)
People (21868)
Pharmaceutical (19)
Pharmacy benefit managers (21)
Phase I (8748)
Phase II (13320)
Phase III (11251)
Pipeline (786)
Policy (56)
Postmarket research (1308)
Preclinical (3567)
Press Release (27)
Prostate cancer (65)
Psychedelics (25)
Radiopharmaceuticals (122)
Rare diseases (227)
Real estate (2868)
Recruiting (46)
Regulatory (10764)
Reports (21)
Research institute (1351)
Resumes & cover letters (101)
Rett syndrome (5)
RNA editing (2)
RSV (15)
Schizophrenia (35)
Series A (48)
Series B (39)
Sickle cell disease (33)
Special edition (7)
Spinal muscular atrophy (105)
Sponsored (14)
Startups (1420)
State (2)
Stomach cancer (7)
Supply chain (29)
Tariffs (11)
The Weekly (5)
Vaccines (239)
Venture capitalists (8)
Weight loss (91)
Women's health (15)
Worklife (10)
Date
Today (99)
Last 7 days (445)
Last 30 days (1245)
Last 365 days (16051)
2025 (5116)
2024 (17291)
2023 (19554)
2022 (25996)
2021 (26996)
2020 (25597)
2019 (21679)
2018 (16398)
2017 (14750)
2016 (13650)
2015 (15461)
2014 (11076)
2013 (9131)
2012 (9656)
2011 (9853)
2010 (8681)
Location
Africa (317)
Alabama (36)
Alaska (3)
Arizona (74)
Arkansas (7)
Asia (17536)
Australia (3046)
California (2876)
Canada (953)
China (281)
Colorado (131)
Connecticut (115)
Delaware (80)
Europe (40287)
Florida (423)
Georgia (93)
Idaho (21)
Illinois (218)
India (14)
Indiana (146)
Iowa (5)
Japan (106)
Kansas (49)
Kentucky (15)
Louisiana (9)
Maine (29)
Maryland (375)
Massachusetts (2007)
Michigan (106)
Minnesota (155)
Mississippi (1)
Missouri (55)
Montana (12)
Nebraska (14)
Nevada (26)
New Hampshire (49)
New Jersey (892)
New Mexico (15)
New York (923)
North Carolina (482)
North Dakota (4)
Northern California (1294)
Ohio (104)
Oklahoma (9)
Oregon (17)
Pennsylvania (627)
Puerto Rico (7)
Rhode Island (17)
South America (440)
South Carolina (14)
South Dakota (1)
Southern California (1037)
Tennessee (70)
Texas (468)
United States (10901)
Utah (81)
Virginia (82)
Washington D.C. (25)
Washington State (278)
West Virginia (3)
Wisconsin (26)
288,382 Results for "ben venue laboratories".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Venus Concept Announces Australian Regulatory Approval for Venus Versa Pro
Venus Concept Inc., a global medical aesthetic technology leader, announced that it has Therapeutic Goods Administration clearance in Australia to market the Venus Versa Pro system.
April 3, 2024
·
3 min read
Press Releases
Venus Concept to Release First Quarter of Fiscal Year 2025 Financial Results on May 15, 2025
April 7, 2025
·
1 min read
Business
Actio Biosciences Appoints Ben Cravatt, Ph.D., to Board of Directors
Actio Biosciences, a biotechnology company leveraging a novel platform approach to genetics and precision medicine to develop new therapeutics that target shared underlying biology in both rare and common diseases, today announced that Ben Cravatt, Ph.D., has joined the company’s board of directors.
May 22, 2024
·
2 min read
Press Releases
Evoke Pharma Announces the Appointment of Ben Smeal to the Board of Directors
October 23, 2024
·
4 min read
MASH
7 Late-Stage MASH Candidates That Could Reshape the Market
Akero Therapeutics, 89bio, Boston Pharmaceuticals and more are working to bring novel treatment options for metabolic dysfunction-associated steatohepatitis to a market that could reach $16 billion by 2033.
April 7, 2025
·
6 min read
·
Ben Hargreaves
Venus Concept Celebrates Successful Completion of its NEXThetics Events Across North America
Venus Concept Inc. announces the successful completion of its NEXThetics events held across several major cities in North America.
June 27, 2024
·
3 min read
Press Releases
Venus Concept Announces Australian Regulatory Approval for Venus Bliss MAX
September 18, 2024
·
3 min read
Manufacturing
GLP-1 Injectables Will Soon Be Joined by Orals. Is the Industry Ready to Scale?
With crucial lessons learned from the manufacturing shortages of injectable GLP-1s, experts say securing adequate supply of the upcoming oral options will be the sector’s next great challenge.
March 26, 2025
·
6 min read
·
Ben Hargreaves
Business
Venus Concept Announces Fourth Quarter and Fiscal Year 2023 Financial Results
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and twelve months ended December 31, 2023.
April 1, 2024
·
19 min read
GLP-1
GLP-1 Drug Boom Recalls the Rise of PD-1 Checkpoint Inhibitors
The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences suggest history may not repeat itself.
March 19, 2025
·
8 min read
·
Ben Hargreaves
1 of 28,839
Next
